Skip to main content

Table 1 Baseline characteristics of patients included in the study (n = 42)

From: Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study

Variable

Control (n = 21)

Intervention (n = 21)

Age (years)

55.0 (9.5)

58.6 (11.0)

Sex

 Male

38.1% (n = 08)

52.4% (n = 11)

 Female

61.9% (n = 13)

47.6% (n = 10)

Income (Reais, R$)

1028.2 (556.9)

1168.9 (602.8)

Schooling

 Illiterate

14.3% (n = 3)

19.0% (n = 4)

 Incomplete elementary school

61.9% (n = 13)

61.9% (n = 13)

 Complete elementary school

14.3% (n = 03)

4.8% (n = 01)

 Incomplete high school

4.8% (n = 01)

9.5% (n = 02)

 High school

4.8% (n = 01)

4.8% (n = 01)

Ejection fraction (%)

45.7(14.8)

44.2(14.0)

Weight (kg)

67.3 (11.3)

69.1 (14.1)

Height (m)

1.56 (0.1)

1.60 (0.1)

Body mass index (kg/m2)

27.7 (5.2)

27.0 (4.7)

Brachial circumference (cm)

29.4 (4.2)

28.3 (3.9)

Triceps skinfold thickness (mm)

18.4 (11.1)

15.1 (7.7)

Brachial muscle circumference (cm)

23.3 (2.6)

23.7 (2.8)

Waist circumference (cm)

87.0 (9.6)

89.0 (12.8)

Hip circumference (cm)

100.4 (10.0)

99.5 (10.9)

Triacylglycerol (mg/dL)

93.8 (39.5)

97.7 (50.9)

Total cholesterol (mg/dL)

166.7 (27.5)

171.7 (38.8)

HDL-cholesterol (mg/dL)

50.4 (13.4)

51.1 (16.2)

LDL-cholesterol (mg/dL)

97.5 (23.2)

105.8 (32.9)

VLDL-cholesterol (mg/dL)

18.8 (8.0)

18.8 (9.1)

Glucose (mg/dL)

93.8 (9.5)

95.6 (8.0)

Tumour necrosis factor-α

66.4 (20.9)

65.6 (19.1)

Interleukin-4

22.2 (6.6)

23.1 (9.2)

Interleukin-6

335.4 (486.9)

163.9 (142.1)

Interleukin-8

84.8 (58.1)

59.8 (26.2)

Interleukin-10

105.2 (71.2)

70.4 (28.4)

Interleukin-33

77.2 (23.6)

86.7 (66.5)

Interleukin-1b

21.1 (8.9)

18.9 (4.4)

Interleukin-17a

5082.3 (5086.2)

3940.4 (4685.9)

Interferon-γ

75.5 (112.9)

47.8 (84.2)

  1. Data are expressed as means (standard deviation) and prevalence of frequency